Developer docs
API playgroundTry for free, no card

Search company profiles

Arcagy-Gineco

Full company profile

uuid002ikae

Namestring
Arcagy-Gineco
Legal namestring
ARCAGY-GINECO
Websiteurl
arcagy.org
Company typeenum
Private
Founded yearint
1993
Descriptiontext

ARCAGY-GINECO is an independent, non-profit academic cooperative clinical research group founded in 1993 and headquartered at 8 Rue Lamennais, Paris (8th arrondissement). The organization specializes exclusively in clinical and translational research in gynecological cancers (ovarian, uterine, cervical, rare gynecological malignancies) and metastatic breast cancer. It coordinates multi-center clinical trials across a network of 400 international partner centers, with 16,500+ patients enrolled and 1,000+ scientific publications produced over 30+ years of operation.

Its core technology and offerings include the GINECO Clinical Studies Platform (coordinating multi-center trials across cancer types), a Professional Portal (gated access for healthcare professionals to study presentations, ASCO materials, and publications), the InfoCancer public information portal, and translational research infrastructure (GEBIG pathologist committee, GINEGEPS sub-group). A recent tool extension is the KELIM Biomarker Kinetics score, developed with Pr. Benoit You as a biomarker kinetics assessment tool and mobile application. The organization also issues standardized protocols (Règlements et procédures du GINECO) and operates sub-brands including GEBIG, GINEGEPS, and InfoCancer.

ARCAGY-GINECO's business model is non-commercial. Under French Association Loi de 1901 (registered SIRET 40236473100024, declared to the Préfécture de Police de Paris on 18 August 1993), it generates no product or service revenue. Funding derives from four streams: (1) private pharmaceutical industry research grants, (2) public research grants from INCa (Institut National du Cancer) and Ligue contre le cancer, (3) member contributions (cotisations), and (4) charitable donations. The go-to-market is community-led and event-driven: scientific congresses (ASCO, Rencontres Scientifiques du GINECO, Saint Paul de Vence), a gated professional portal, and a public LinkedIn presence. The organization serves oncology specialists, gynecologists, pathologists, and clinical research coordinators across its partner center network, with secondary reach to patient populations via the InfoCancer portal.

Short descriptiontext

ARCAGY-GINECO is a Paris-based non-profit academic cooperative research group founded in 1993 that coordinates multi-center clinical trials in gynecological cancers and metastatic breast cancer across 400 international partner centers, funded by research grants, public subsidies, and donations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial coordination, gynecological cancer research, translational oncology research, academic research consortium, breast cancer research
Industry3 codes
PRIMARYHLAKAJAD
Gynecologic Oncology
SECONDARYHLAFAJAK
Gynecologic Oncology & Women’s Cancer Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAFAB
Medical Oncology
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Research Grants - Pharmaceutical Industry
TypeSubscription Recurring
Description

Private pharmaceutical industry provides research grants to fund clinical trials and research activities

arcagy.org
2Public Research Grants
TypeSubscription Recurring
Description

Funding from public organisms including Institut National du Cancer (INCa) and Ligue contre le cancer for cancer research initiatives

arcagy.org
3Member Contributions
TypeSubscription Recurring
Description

Cotisations (membership fees) from member healthcare professionals and institutions

arcagy.org
4Donations
TypeGrants Donations
Description

Charitable donations from individuals and organizations supporting gynecological cancer research

arcagy.org
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1GINECO
Description

The main clinical research group within ARCAGY specializing in gynecological cancer clinical trials.

arcagy.org
+3 more records
Core offering1 text field

ARCAGY-GINECO designs, coordinates, and conducts multi-center clinical trials and translational research in gynecological cancers (ovarian, uterine, cervical) and metastatic breast cancer through a cooperative network of 400 international partner centers. It also operates the InfoCancer cancer-information portal and a gated Professional Portal providing healthcare professionals with access to study presentations, ASCO materials, and scientific publications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 16,500 patients included in clinical trials across gynecological and breast cancer research
+2 more records
Product overview1 text field

ARCAGY-GINECO is a non-profit academic clinical research group operating primarily through two integrated offerings: (1) the GINECO Clinical Studies Platform, which coordinates international clinical trials in gynecological cancers and metastatic breast cancer, and (2) the InfoCancer Portal, a public-facing cancer information platform. These are complemented by a Professional Portal providing restricted access to healthcare professionals for study materials and publications. The organization manages over 16,500 patients enrolled across clinical trials and maintains partnerships with approximately 400 international centers. The product portfolio focuses on research coordination, data management for clinical studies, and public/medical education rather than commercial software products.

Product and service4 records
1InfoCancer Portal
CategoryCancer information / public education platform
Description

A comprehensive cancer information portal providing scientifically validated and regularly updated information on multiple cancers, including gynecological cancers and breast cancer, for the general public and healthcare professionals.

2GINECO Clinical Studies Platform
CategoryClinical trial coordination / research platform
Description

An academic clinical research platform coordinating and conducting clinical trials in gynecological cancers (ovarian, uterine, cervical, rare gynecological malignancies) and metastatic breast cancer. It manages patient enrollment, study protocols, and international research collaborations across 400 partner centers.

3Professional Portal
CategoryProfessional content access platform
Description

A restricted-access professional area providing healthcare professionals with private study presentations, GINECO publications, ASCO presentations, and scientific meeting materials. Access requires registration and administrator validation.

4Biomarker Kinetics (KELIM score) Tool
CategoryResearch tool / biomarker analysis
Description

An external website and mobile application providing biomarker kinetics modeling, featuring the KELIM score, associated with GINECO research activities.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

French national cancer institute providing public research funding and institutional support for cancer research initiatives conducted by ARCAGY-GINECO.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

French cancer league providing research grants and institutional support for cancer research activities.

3Groupe Coopératif Oncologie (GCO)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cooperative oncology group network that ARCAGY-GINECO participates in as an intergroup, collaborating on cancer research initiatives and sharing activity reports.

arcagy.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dedicated website for rare gynecological tumors operated as a partner site, supporting research and information dissemination for rare ovarian cancers.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Patient advocacy organization partner supporting awareness and research for gynecological cancers.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Oncology publication platform featuring the GINECO review in their magazine, supporting scientific communication and knowledge dissemination.

Strategic tierSecondaryTypeTechnology or Integration
Description

Collaborative initiative with Pr. Benoit You for the Biomarker Kinetics website and mobile application featuring the KELIM score for biomarker analysis.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Network of 400 international clinical research centers participating in GINECO clinical trials, recruiting patients and conducting research according to standardized protocols.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1BGOG (Belgian and Luxembourg Gynaecological Oncology Group)
TypeRegional player
Description

Belgian-Luxembourg cooperative group running gynecologic oncology trials. Comparable in cooperative structure and clinical research scope, but operating primarily in Belgium and Luxembourg.

2AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)
TypeRegional player
Description

German gynecologic oncology study group running multi-center trials and translational research in ovarian, uterine, and breast cancers. Comparable in mission, structure, and scientific focus but serves the DACH region primarily.

3Unicancer
TypeBroad incumbent
Description

French network of Comprehensive Cancer Centers (CLCCs) and academic cooperative groups, of which ARCAGY-GINECO is a member. Comparable as a coordinating body for oncology research and care in France.

TypeDirect peer
Description

International coalition of cooperative groups conducting clinical trials in gynecologic cancers. Directly comparable as a peer cooperative network operating at a similar international scale and focus area.

TypeOthers
Description

French research institute focused on genetic diseases with translational research expertise. Adjacent in the academic translational medicine ecosystem in Paris, sharing institutional access to investigator networks and translational methodologies.

TypeBroad incumbent
Description

European Organisation for Research and Treatment of Cancer — pan-European cooperative running oncology trials across multiple tumor types. Comparable as a peer research cooperative, though broader in tumor-type coverage.

TypeRegional player
Description

Nordic cooperative group conducting gynecologic oncology clinical trials across Scandinavia. Similar trial-coordination model and cancer-type focus, but concentrated in Nordic countries.

TypeDirect peer
Description

European umbrella network of national gynecological oncology cooperative groups, including GINECO. Directly comparable as a coordinating body for gynecologic cancer clinical trials across European centers.

9NCRI (National Cancer Research Institute)
TypeBroad incumbent
Description

UK-based partnership of cancer research funders and bodies that coordinate clinical trial activity. Comparable as a coordinating organization in cancer research, although broader in scope and geography.

TypeBroad incumbent
Description

Large US-based NCI-funded cooperative group conducting gynecologic oncology trials (legacy Gynecologic Oncology Group). Comparable in trial focus area but operates at significantly larger scale and is part of a broader oncology portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arcagy-Gineco

Clinical Research Servicesarcagy.org

ARCAGY-GINECO is a Paris-based non-profit academic cooperative research group founded in 1993 that coordinates multi-center clinical trials in gynecological cancers and metastatic breast cancer across 400 international partner centers, funded by research grants, public subsidies, and donations.

What Arcagy-Gineco does

ARCAGY-GINECO is an independent, non-profit academic cooperative clinical research group founded in 1993 and headquartered at 8 Rue Lamennais, Paris (8th arrondissement). The organization specializes exclusively in clinical and translational research in gynecological cancers (ovarian, uterine, cervical, rare gynecological malignancies) and metastatic breast cancer. It coordinates multi-center clinical trials across a network of 400 international partner centers, with 16,500+ patients enrolled and 1,000+ scientific publications produced over 30+ years of operation.

Its core technology and offerings include the GINECO Clinical Studies Platform (coordinating multi-center trials across cancer types), a Professional Portal (gated access for healthcare professionals to study presentations, ASCO materials, and publications), the InfoCancer public information portal, and translational research infrastructure (GEBIG pathologist committee, GINEGEPS sub-group). A recent tool extension is the KELIM Biomarker Kinetics score, developed with Pr. Benoit You as a biomarker kinetics assessment tool and mobile application. The organization also issues standardized protocols (Règlements et procédures du GINECO) and operates sub-brands including GEBIG, GINEGEPS, and InfoCancer.

ARCAGY-GINECO's business model is non-commercial. Under French Association Loi de 1901 (registered SIRET 40236473100024, declared to the Préfécture de Police de Paris on 18 August 1993), it generates no product or service revenue. Funding derives from four streams: (1) private pharmaceutical industry research grants, (2) public research grants from INCa (Institut National du Cancer) and Ligue contre le cancer, (3) member contributions (cotisations), and (4) charitable donations. The go-to-market is community-led and event-driven: scientific congresses (ASCO, Rencontres Scientifiques du GINECO, Saint Paul de Vence), a gated professional portal, and a public LinkedIn presence. The organization serves oncology specialists, gynecologists, pathologists, and clinical research coordinators across its partner center network, with secondary reach to patient populations via the InfoCancer portal.

Arcagy-Gineco firmographics

Firmographics
Name
Arcagy-Gineco
Legal name
ARCAGY-GINECO
Website
https://arcagy.org
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
11–50 employees
Short description
ARCAGY-GINECO is a Paris-based non-profit academic cooperative research group founded in 1993 that coordinates multi-center clinical trials in gynecological cancers and metastatic breast cancer across 400 international partner centers, funded by research grants, public subsidies, and donations.
Ownership category
akta.pro rank

Arcagy-Gineco industry classification

Industry
Product category
Clinical Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAKAJAD
Gynecologic Oncology
SECONDARYHLAFAJAK
Gynecologic Oncology & Women’s Cancer Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAFAB
Medical Oncology

Keywords

  • Clinical trial coordination
  • Gynecological cancer research
  • Translational oncology research
  • Academic research consortium
  • Breast cancer research

Where Arcagy-Gineco is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Arcagy-Gineco business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Research Grants - Pharmaceutical Industry: Private pharmaceutical industry provides research grants to fund clinical trials and research activities
  2. Public Research Grants: Funding from public organisms including Institut National du Cancer (INCa) and Ligue contre le cancer for cancer research initiatives
  3. Member Contributions: Cotisations (membership fees) from member healthcare professionals and institutions
  4. Donations: Charitable donations from individuals and organizations supporting gynecological cancer research

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Arcagy-Gineco product offering

Product offering

Core offering

ARCAGY-GINECO designs, coordinates, and conducts multi-center clinical trials and translational research in gynecological cancers (ovarian, uterine, cervical) and metastatic breast cancer through a cooperative network of 400 international partner centers. It also operates the InfoCancer cancer-information portal and a gated Professional Portal providing healthcare professionals with access to study presentations, ASCO materials, and scientific publications.

Product overview

ARCAGY-GINECO is a non-profit academic clinical research group operating primarily through two integrated offerings: (1) the GINECO Clinical Studies Platform, which coordinates international clinical trials in gynecological cancers and metastatic breast cancer, and (2) the InfoCancer Portal, a public-facing cancer information platform. These are complemented by a Professional Portal providing restricted access to healthcare professionals for study materials and publications. The organization manages over 16,500 patients enrolled across clinical trials and maintains partnerships with approximately 400 international centers. The product portfolio focuses on research coordination, data management for clinical studies, and public/medical education rather than commercial software products.

Differentiator

Problem solved

Functional benefit

Brands

  • GINECO: The main clinical research group within ARCAGY specializing in gynecological cancer clinical trials.
  • GINEGEPS
  • GEBIG
  • InfoCancer

Products and services

  • InfoCancer Portal A comprehensive cancer information portal providing scientifically validated and regularly updated information on multiple cancers, including gynecological cancers and breast cancer, for the general public and healthcare professionals.
  • GINECO Clinical Studies Platform An academic clinical research platform coordinating and conducting clinical trials in gynecological cancers (ovarian, uterine, cervical, rare gynecological malignancies) and metastatic breast cancer. It manages patient enrollment, study protocols, and international research collaborations across 400 partner centers.
  • Professional Portal A restricted-access professional area providing healthcare professionals with private study presentations, GINECO publications, ASCO presentations, and scientific meeting materials. Access requires registration and administrator validation.
  • Biomarker Kinetics (KELIM score) Tool An external website and mobile application providing biomarker kinetics modeling, featuring the KELIM score, associated with GINECO research activities.

Quantifiable outcome

  • 16,500 patients included in clinical trials across gynecological and breast cancer research
  • +2 more outcomes

Companies that use Arcagy-Gineco

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Arcagy-Gineco technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Arcagy-Gineco partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and secondary.

  • Institut National du Cancer (INCa)coreStrategic or Co-development PartnerFrench national cancer institute providing public research funding and institutional support for cancer research initiatives conducted by ARCAGY-GINECO.
  • Ligue contre le cancercoreStrategic or Co-development PartnerFrench cancer league providing research grants and institutional support for cancer research activities.
  • Groupe Coopératif Oncologie (GCO)coreStrategic or Co-development PartnerCooperative oncology group network that ARCAGY-GINECO participates in as an intergroup, collaborating on cancer research initiatives and sharing activity reports.
  • Ovaire Rare (TMRG)coreStrategic or Co-development PartnerDedicated website for rare gynecological tumors operated as a partner site, supporting research and information dissemination for rare ovarian cancers.
  • ImagynsecondaryStrategic or Co-development PartnerPatient advocacy organization partner supporting awareness and research for gynecological cancers.
  • Onko+secondaryStrategic or Co-development PartnerOncology publication platform featuring the GINECO review in their magazine, supporting scientific communication and knowledge dissemination.
  • Biomarker KineticssecondaryTechnology or IntegrationCollaborative initiative with Pr. Benoit You for the Biomarker Kinetics website and mobile application featuring the KELIM score for biomarker analysis.
  • 400 International Partner CenterscoreChannel Partner/ Reseller/ DistributorNetwork of 400 international clinical research centers participating in GINECO clinical trials, recruiting patients and conducting research according to standardized protocols.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Arcagy-Gineco competitors and assessment

Company assessment

Regional players

  • BGOG (Belgian and Luxembourg Gynaecological Oncology Group): Belgian-Luxembourg cooperative group running gynecologic oncology trials. Comparable in cooperative structure and clinical research scope, but operating primarily in Belgium and Luxembourg.
  • AGO (Arbeitsgemeinschaft Gynäkologische Onkologie): German gynecologic oncology study group running multi-center trials and translational research in ovarian, uterine, and breast cancers. Comparable in mission, structure, and scientific focus but serves the DACH region primarily.
  • NSGO (Nordic Society of Gynecological Oncology): Nordic cooperative group conducting gynecologic oncology clinical trials across Scandinavia. Similar trial-coordination model and cancer-type focus, but concentrated in Nordic countries.

Broad incumbents

  • Unicancer: French network of Comprehensive Cancer Centers (CLCCs) and academic cooperative groups, of which ARCAGY-GINECO is a member. Comparable as a coordinating body for oncology research and care in France.
  • EORTC: European Organisation for Research and Treatment of Cancer — pan-European cooperative running oncology trials across multiple tumor types. Comparable as a peer research cooperative, though broader in tumor-type coverage.
  • NCRI (National Cancer Research Institute): UK-based partnership of cancer research funders and bodies that coordinate clinical trial activity. Comparable as a coordinating organization in cancer research, although broader in scope and geography.
  • NRG Oncology (formerly GOG): Large US-based NCI-funded cooperative group conducting gynecologic oncology trials (legacy Gynecologic Oncology Group). Comparable in trial focus area but operates at significantly larger scale and is part of a broader oncology portfolio.

Direct peers

Others

  • Imagine Institute / Institut Imagine: French research institute focused on genetic diseases with translational research expertise. Adjacent in the academic translational medicine ecosystem in Paris, sharing institutional access to investigator networks and translational methodologies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Arcagy-Gineco social profiles

Digital presence

Arcagy-Gineco compliance and trust

Trust signal

Compliance3 records

Arcagy-Gineco financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arcagy-Gineco leadership team

Management profile

Number of profiles

Profiles2 records

Arcagy-Gineco funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arcagy-Gineco M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arcagy-Gineco

What does Arcagy-Gineco do?

ARCAGY-GINECO designs, coordinates, and conducts multi-center clinical trials and translational research in gynecological cancers (ovarian, uterine, cervical) and metastatic breast cancer through a cooperative network of 400 international partner centers. It also operates the InfoCancer cancer-information portal and a gated Professional Portal providing healthcare professionals with access to study presentations, ASCO materials, and scientific publications.

Is Arcagy-Gineco a public or private company?

Arcagy-Gineco is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Arcagy-Gineco founded?

Arcagy-Gineco was founded in 1993. It employs 11 to 50 people.

Where is Arcagy-Gineco based?

Arcagy-Gineco is headquartered in Paris, France, in the Europe region.

How does Arcagy-Gineco make money?

Four revenue lines are on record. Research Grants - Pharmaceutical Industry is the primary driver. The others are public Research Grants, member Contributions and donations.

Who are Arcagy-Gineco's main competitors?

Regional players on record are BGOG (Belgian and Luxembourg Gynaecological Oncology Group), AGO (Arbeitsgemeinschaft Gynäkologische Onkologie) and NSGO (Nordic Society of Gynecological Oncology). Broad incumbents are Unicancer, EORTC, NCRI (National Cancer Research Institute) and NRG Oncology (formerly GOG). Direct peers are GCIG (Gynecologic Cancer InterGroup) and ENGOT (European Network of Gynecological Oncological Trial groups). Imagine Institute / Institut Imagine is listed as an others.

Does Arcagy-Gineco have an API?

No public API is recorded for Arcagy-Gineco.

What industry is Arcagy-Gineco in?

Arcagy-Gineco's product category is Clinical Research Services. Its primary akta.pro industry code is HLAKAJAD, Gynecologic Oncology, with a secondary code of HLAFAJAK, Gynecologic Oncology & Women’s Cancer Centers. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals